Paper33716239
Silencing circRNA protein kinase C iota (circ-PRKCI) suppresses cell progression and glycolysis of human papillary thyroid cancer through circ-PRKCI/miR-335/E2F3 ceRNA axis.
Liu Y and 5 others. Endocr J, 2021. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Silencing circRNA protein kinase C iota (circ-PRKCI) suppresses cell progression and glycolysis of human papillary thyroid cancer through circ-PRKCI/miR-335/E2F3 ceRNA axis. Papers, record 33716239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33716239
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Silencing circRNA protein kinase C iota (circ-PRKCI) suppresses cell progression and glycolysis of human papillary thyroid cancer through circ-PRKCI/miR-335/E2F3 ceRNA axis.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Cycle | Major topic |
| Glycolysis | Major topic |
| Isoenzymes | Major topic |
| Protein Kinase C | Major topic |
| RNA, Circular | Major topic |
| Thyroid Cancer, Papillary | Major topic |
| Thyroid Neoplasms | Major topic |
| Adult | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Female | |
| Gene Expression Regulation, Neoplastic | |
| Gene Silencing | |
| Humans | |
| Male | |
| MicroRNAs | |
| Middle Aged | |
| Signal Transduction | |
| Protein Kinase C-lambda |
Source PubMed
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41057823 | Exosome-mediated metabolic reprogramming: effects on thyroid cancer progression and tumor microenvironment remodeling. | Mol Cancer | 2025 | https://conductscience.org/library/papers/41057823 | PubMed |
| 40386233 | Has_circRNA_0122683 (circ-PRKCI) relieves ferroptosis of HPAEpiCs in sepsis-induced acute lung injury by sponging miR-382-5p. | PeerJ | 2025 | https://conductscience.org/library/papers/40386233 | PubMed |
| 39901896 | Circular RNAs in cancer. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/39901896 | PubMed |
| 39838328 | BRAF regulates circPSD3/miR-526b/RAP2A axis to hinder papillary thyroid carcinoma progression. | BMC Mol Cell Biol | 2025 | https://conductscience.org/library/papers/39838328 | PubMed |
| 38988519 | hsa_circ_0101050 regulated by ZC3H13 enhances tumorigenesis in papillary thyroid cancer via m6A modification. | Heliyon | 2024 | https://conductscience.org/library/papers/38988519 | PubMed |
| 38892280 | Circular RNAs in Cell Cycle Regulation of Cancers. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38892280 | PubMed |
| 38741779 | Circular RNA PRKCI (hsa_circ_0067934): a potential target in the pathogenesis of human malignancies. | Front Oncol | 2024 | https://conductscience.org/library/papers/38741779 | PubMed |
| 38544689 | The emerging role and clinical significance of circRNAs in papillary thyroid cancer. | Front Endocrinol (Lausanne) | 2024 | https://conductscience.org/library/papers/38544689 | PubMed |
| 38394156 | CircSEMA6A upregulates PRRG4 by targeting MiR-520h and recruiting ELAVL1 to affect cell invasion and migration in papillary thyroid carcinoma. | Arch Endocrinol Metab | 2024 | https://conductscience.org/library/papers/38394156 | PubMed |
| 38316961 | Emerging roles of circular RNAs in regulating the hallmarks of thyroid cancer. | Cancer Gene Ther | 2024 | https://conductscience.org/library/papers/38316961 | PubMed |
| 37031335 | Hsa_circITGA4/ miR-1468/EGFR/ PTEN a Master Regulators Axis in Glioblastoma Development and Progression. | Mol Biotechnol | 2024 | https://conductscience.org/library/papers/37031335 | PubMed |
| 36230649 | A Review and In Silico Analysis of Tissue and Exosomal Circular RNAs: Opportunities and Challenges in Thyroid Cancer. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36230649 | PubMed |
| 35936780 | Function and Clinical Significance of Circular RNAs in Thyroid Cancer. | Front Mol Biosci | 2022 | https://conductscience.org/library/papers/35936780 | PubMed |
| 35694090 | Bioinformatics analysis of downstream circRNAs and miRNAs regulated by Runt-related transcription factor 1 in papillary thyroid carcinoma. | Gland Surg | 2022 | https://conductscience.org/library/papers/35694090 | PubMed |
| 34239306 | Circular RNAs Regulate Glucose Metabolism in Cancer Cells. | Onco Targets Ther | 2021 | https://conductscience.org/library/papers/34239306 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| E2F3 | 1871 | PubTator's text mining | https://conductscience.org/library/genes/1871 | NCBI Gene |
| MIR335 | 442904 | PubTator's text mining | https://conductscience.org/library/genes/442904 | NCBI Gene |
| MMP2 | 4313 | PubTator's text mining | https://conductscience.org/library/genes/4313 | NCBI Gene |
| MMP9 | 4318 | PubTator's text mining | https://conductscience.org/library/genes/4318 | NCBI Gene |
| PRKCI | 5584 | PubTator's text mining | https://conductscience.org/library/genes/5584 | NCBI Gene |
| SNAI1 | 6615 | PubTator's text mining | https://conductscience.org/library/genes/6615 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33716239
GET https://conductscience.org/api/papers/v1/33716239/authors